Mortality from cirrhosis: lack of progress over the last 35 years
Open accessAbstract
Despite increased knowledge of hamstring muscle injuries, the incidence has not diminished. We now know that not all hamstring injuries are the same and that certain types of injuries require prolonged rehabilitation and return to play. The slow stretch type of injury and injuries involving the central tendon both require longer times to return to play. A number of factors have been proposed as being indicators of time taken to return to play, but the evidence for these is conflicting. Recurrence rates remain high and it is now thought that strength deficits may be an important factor. Strengthening exercise should be performed with the hamstrings in a lengthened position. There is conflicting evidence regarding the efficacy of platelet-rich plasma injection in the treatment of hamstring injuries so at this stage we cannot advise their use. Various tests have been proposed as predictors of hamstring injury and the use of the Nordboard is an interesting addition to the testing process. Prevention of these injuries is the ultimate aim and there is increasing evidence that Nordic hamstring exercises are effective in reducing the incidence.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
With the exception of liver transplantation, treatment for cirrhosis has been shown to, at most, minimally improve long-term survival in patients with decompensated liver cirrhosis.
“In addition, with the exception of liver transplantation, treatment for cirrhosis has been shown to, at most, minimally improve long-term survival in patients with decompensated liver cirrhosis [21,91,92].”
From Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis (2014) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2 retracted
S-adenosyl-L-methionine for alcoholic liver diseases
Rambaldi, A., & Gluud, C. N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002235.pub2 · Cited by 124 · see citing works
Self-citationRetractedS-adenosyl-L-methionine for alcoholic liver diseases
Rambaldi, A., & Gluud, C. N. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002235 · Cited by 36 · see citing works
Self-citationRetractedCochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048 · see citing works
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,361 · see citing works
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312 · see citing works
Cochrane Handbook for Systematic Reviews of Interventions
Higgins, J. P. T., Green, S., & Ben Van Den, A. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.123 · Cited by 5,670 · see citing works
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · see citing works
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · see citing works
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793 · see citing works
de Franchis, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.004 · Cited by 2,291 · see citing works
Gluud, L. L., Villumsen, J., & Gluud, C. N. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00010 · Cited by 2,262 · see citing works
Self-citationLamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y., Sung, J. J. �., Chow, W. C., Farrell, G. C., Lee, C., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,259 · see citing works
The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,909 · see citing works
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature reviews. Immunology · doi:10.1038/nri1132 · Cited by 1,882 · see citing works
Schaff, Z., & Csmos, G. (1994) · Cited by 1,869 · see citing works
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Núñez, G., & Flavell, R. A. (2005) · Science · doi:10.1126/science.1104911 · Cited by 1,776 · see citing works
Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2
Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S., Hashimoto, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200673200 · Cited by 1,694 · see citing works
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · see citing works
Interactions between commensal intestinal bacteria and the immune system
Macpherson, A. J., & Harris, N. L. (2004) · Nature reviews. Immunology · doi:10.1038/nri1373 · Cited by 1,607 · see citing works
Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S., et al. (2003) · Nature Immunology · doi:10.1038/ni945 · Cited by 1,323 · see citing works
Apoptosis control by death and decoy receptors
Ashkenazi, A., & Dixit, V. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80034-9 · Cited by 1,281 · see citing works
Hampe, J., Cuthbert, A. P., Croucher, P. J. P., Mirza, M. M., Mascheretti, S., Fisher, S. A., Frenzel, H., King, K., Hasselmeyer, A., Macpherson, A. J., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05063-7 · Cited by 1,090 · see citing works
NODs: intracellular proteins involved in inflammation and apoptosis
Inohara, N., & Núñez, G. (2003) · Nature reviews. Immunology · doi:10.1038/nri1086 · Cited by 1,063 · see citing works
de Franchis, R. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.009 · Cited by 1,029 · see citing works
NOD-LRR PROTEINS: Role in Host-Microbial Interactions and Inflammatory Disease
Inohara, N., Chamaillard, M., McDonald, C., & Núñez, G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133347 · Cited by 993 · see citing works
Cytokines in Alcoholic and Nonalcoholic Steatohepatitis
Tilg, H., & Diehl, A. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432007 · Cited by 935 · see citing works
RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems
Kobayashi, K. S., Inohara, N., Hernandez, L. D., Galán, J. E., Núñez, G., Janeway, C. A., Medzhitov, R. M., & Flavell, R. A. (2002) · Nature · doi:10.1038/416194a · Cited by 888 · see citing works
Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.019 · Cited by 859 · see citing works
Anti–Interleukin-12 Antibody for Active Crohn's Disease
Mannon, P., Fuss, I. J., Mayer, L., Elson, C. O., Sandborn, W. J., Present, D. H., Dolin, B. J., Goodman, N., Groden, C. A., Hornung, R. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033402 · Cited by 844 · see citing works
NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses
Watanabe, T., Kitani, A., Murray, P. J., & Strober, W. (2004) · Nature Immunology · doi:10.1038/ni1092 · Cited by 839 · see citing works
Wehkamp, J., Harder, J., Weichenthal, M., Schwab, M. G., Schäffeler, E., Schlee, M., Herrlinger, K. R., Stallmach, A., Noack, F., Fritz, P., et al. (2004) · Gut · doi:10.1136/gut.2003.032805 · Cited by 823 · see citing works
Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B
Niederau, C., Heintges, T., Lange, S., Goldmann, G., Niederau, C. M., Mohr, L., & Häussinger, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342202 · Cited by 797 · see citing works
Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin
Salzman, N. H., Ghosh, D., Huttner, K. M., Paterson, Y. Y. W., & Bevins, C. L. (2003) · Nature · doi:10.1038/nature01520 · Cited by 765 · see citing works
Als-Nielsen, B., Chen, W., Gluud, C., & Kjaergard, L. L. (2003) · JAMA · doi:10.1001/jama.290.7.921 · Cited by 746 · see citing works
Self-citationLong-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
Hsu, Y.-S., Chien, R., Yeh, C., Sheen, I., Chiou, H., Chu, C., & Liaw, Y. (2002) · Hepatology · doi:10.1053/jhep.2002.33638 · Cited by 705 · see citing works
The Cochrane Database of Systematic Reviews – Issue 4 2008
Clarke, M. J. (2008) · Journal of Evidence-Based Medicine · doi:10.1111/j.1756-5391.2008.00009.x · Cited by 657 · see citing works
Lai, C., Dienstag, J. L., Schiff, E. R., Leung, N. W. Y., Atkins, M., Hunt, C. M., Brown, N. A., Woessner, M. A., Boehme, R. E., & Condreay, L. D. (2003) · Clinical Infectious Diseases · doi:10.1086/368083 · Cited by 633 · see citing works
Identification of Bacterial Muramyl Dipeptide as Activator of the NALP3/Cryopyrin Inflammasome
Martinon, F., Agostini, L., Meylan, E., & Tschopp, J. (2004) · Current Biology · doi:10.1016/j.cub.2004.10.027 · Cited by 579 · see citing works
Modulation of life and death by the TNF receptor superfamily
Baker, S. J., & Reddy, E. P. (1998) · Oncogene · doi:10.1038/sj.onc.1202568 · Cited by 536 · see citing works
EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B
Jury, T. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00378-7 · Cited by 518 · see citing works
Chronic hepatitis B: Update of recommendations† ‡
Lok, A. S.-F., & McMahon, B. J. (2004) · Hepatology · doi:10.1002/hep.20110 · Cited by 504 · see citing works
Relative Citation Impact of Various Study Designs in the Health Sciences
Patsopoulos, N. A. (2005) · JAMA · doi:10.1001/jama.293.19.2362 · Cited by 498 · see citing works
Lack of common NOD2 variants in Japanese patients with Crohn's disease
Inoue, N., Tamura, K., Kinouchi, Y., Fukuda, Y., Takahashi, S., Ogura, Y., Inohara, N., Núñez, G., Kishi, Y., Koike, Y., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34155 · Cited by 483 · see citing works
Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease
Lonardo, A., Adinolfi, L. E., Loria, P., Carulli, N., Ruggiero, G., & Day, C. P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.020 · Cited by 476 · see citing works
Toll-like receptor 9–induced type I IFN protects mice from experimental colitis
Katakura, K., Lee, J., Rachmilewitz, D., Li, G. C., Eckmann, L., & Raz, E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22996 · Cited by 450 · see citing works
Expression of NOD2 in Paneth cells: a possible link to Crohn’s ileitis
Ogura, Y., Lala, S. G., Xin, W., Smith, E., Dowds, T. A., Chen, F. F., Zimmermann, E., Tretiakova, M., Cho, J. H., Hart, J., et al. (2003) · Gut · doi:10.1136/gut.52.11.1591 · Cited by 439 · see citing works
van Bömmel, F., Wünsche, T., Mauss, S., Reinke, P., Bergk, A., Schürmann, D., Wiedenmann, B. J., & Berg, T. (2004) · Hepatology · doi:10.1002/hep.20464 · Cited by 389 · see citing works
Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis
Rachmilewitz, D., Karmeli, F., Takabayashi, K., Hayashi, T., Leider–Trejo, L., Lee, J., Leoni, L. M., & Raz, E. (2002) · Gastroenterology · doi:10.1053/gast.2002.32994 · Cited by 380 · see citing works
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
Yuen, M.-F., Yuan, H.-J., Wong, D. K.-H., et al. (2005) · Gut · doi:10.1136/gut.2005.065136 · Cited by 379 · see citing works
Abbott, D. W., Wilkins, A., Asara, J. M., & Cantley, L. C. (2004) · Current Biology · doi:10.1016/j.cub.2004.12.032 · Cited by 374 · see citing works
A 20-year prospective study of cirrhosis.
Saunders, J. B., Walters, J. R. F., Davies, A., & Paton, A. (1981) · BMJ · doi:10.1136/bmj.282.6260.263 · Cited by 350 · see citing works
Song, B.-C., Suh, D. J., Lee, H. C., Chung, Y., & Lee, Y. S. (2000) · Hepatology · doi:10.1053/jhep.2000.16665 · Cited by 335 · see citing works
Brunetto, M. R., Oliveri, F., Coco, B. A., Leandro, G., Colombatto, P., Gorin, J. M., & Bonino, F. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00266-5 · Cited by 329 · see citing works
Infection, coagulation, and variceal bleeding in cirrhosis
Thalheimer, U., Triantos, C. K., Samonakis, D. N., Patch, D., & Burroughs, A. K. (2005) · Gut · doi:10.1136/gut.2004.048181 · Cited by 317 · see citing works
Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding
Chávez-Tapia, N. C., Barrientos‐Gutiérrez, T., Téllez-Ávila, F. I., Soares‐Weiser, K., & Uribe, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002907.pub2 · Cited by 304 · see citing works
The Natural History of Asymptomatic Hepatitis B Surface Antigen Carriers
de Franchis, R., Meucci, G., Vecchi, M. L., Tatarella, M., Colombo, M., Ninno, E. D., Rumi, M. G., Donato, M. F., & Ronchi, G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00006 · Cited by 291 · see citing works
Grell, M., Zimmermann, G., Gottfried, E., Chen, C., Grünwald, U., Huang, D. C. S., Lee, Y. W., Dürkop, H., Engelmann, H., Scheurich, P., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3034 · Cited by 284 · see citing works
Examining the Role of Paneth Cells in the Small Intestine by Lineage Ablation in Transgenic Mice
Garabedian, E. M., Roberts, L. J., McNevin, M. S., & Gordon, J. I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23729 · Cited by 279 · see citing works
Netea, M. G., Ferwerda, G., de Jong, D. J., Jansen, T., Jacobs, L., Kramer, M., Naber, A. H. J., Drenth, J. P. H., Girardin, S. E., Kullberg, B. J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6518 · Cited by 274 · see citing works
Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection
Chu, C. (2002) · Hepatology · doi:10.1053/jhep.2002.36949 · Cited by 272 · see citing works
Nonalcoholic Fatty Liver Disease: A Clinical Review
Sass, D. A., Chang, P., & Chopra, K. B. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-1267-z · Cited by 267 · see citing works
Role of Nod2 in the Response of Macrophages to Toll-Like Receptor Agonists
Pauleau, A., & Murray, P. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7531-7539.2003 · Cited by 261 · see citing works
Terlipressin for acute esophageal variceal hemorrhage
Ioannou, G. N., Doust, J. A., & Rockey, D. C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002147 · Cited by 255 · see citing works
TRAIL and its receptors as targets for cancer therapy
Yagita∥, H., Takeda, K., Hayakawa, Y., Smyth, M. J., & Okumura, K. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02181.x · Cited by 254 · see citing works
Following a TRAIL: Update on a ligand and its five receptors
Kimberley, F. C., & Screaton, G. R. (2004) · Cell Research · doi:10.1038/sj.cr.7290236 · Cited by 251 · see citing works
TRAIL-induced signalling and apoptosis
MacFarlane, M. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(02)00422-8 · Cited by 240 · see citing works
Krleža-Jerić, K., Chan, A., Dickersin, K., Sim, I., Grimshaw, J., & Gluud, C. N. (2005) · BMJ · doi:10.1136/bmj.330.7497.956 · Cited by 236 · see citing works
Self-citationYuen, M., Hui, C., Cheng, C.-C., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.25273 · Cited by 234 · see citing works
Escorsell, À., Bañares, R., García‐Pagán, J. C., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.30418 · Cited by 232 · see citing works
The Role of APO‐1‐Mediated Apoptosis in the Immune System
Krammer, P. H., Dhein, J., Walczak, H., et al. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00889.x · Cited by 232 · see citing works
Taimr, P., Higuchi, H., Kočová, E., Rippe, R. A., Friedman, S. L., & Gores, G. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50002 · Cited by 228 · see citing works
Interventions for paracetamol (acetaminophen) overdose
Brok, J. S., Buckley, N., & Gluud, C. N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003328.pub2 · Cited by 227 · see citing works
Self-citationVariceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding
de la Peña, J., Brullet, E., Sánchez, E., et al. (2005) · Hepatology · doi:10.1002/hep.20584 · Cited by 211 · see citing works
Yamada, Y., & Fausto, N. (1998) · Europe PMC (PubMed Central) · Cited by 208 · see citing works
Yang, S., Tamai, R., Akashi, S., Takeuchi, O., Akira, S., Sugawara, S., & Takada, H. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2045-2053.2001 · Cited by 207 · see citing works
Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation
Hilliard, B. A., Mason, N. J., Xu, L., Sun, J., Lamhamedi-Cherradi, S.-E., Liou, H., Hunter, C. A., & Chen, Y. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15254 · Cited by 201 · see citing works
Meta‐analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding
Khuroo, M. S., Khuroo, N. S., Farahat, K., Khuroo, Y. S., Sofi, A. A., & Dahab, S. T. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02346.x · Cited by 199 · see citing works
Ganten, T. M., Haas, T. L., Sýkora, J., Stahl, H. F., Sprick, M. R., Fas, S. C., Krueger, A., Weigand, M. A., Große-Wilde, A., Stremmel, W., et al. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401437 · Cited by 198 · see citing works
Afford, S. C., Randhawa, S., Eliopoulos, A. G., Hübscher, S. G., Young, L. S., & Adams, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.441 · Cited by 192 · see citing works
TIPS versus paracentesis for cirrhotic patients with refractory ascites
Saab, S., Nieto, J. M., Lewis, S. K., & Runyon, B. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004889.pub2 · Cited by 181 · see citing works
Degranulation of paneth cells via toll-like receptor 9.
Rumio, C., Besusso, D., Palazzo, M., Selleri, S., Sfondrini, L., Dubini, F., Ménard, S., & Balsari, A. (2004) · American Journal of Pathology · doi:10.1016/s0002-9440(10)63304-4 · Cited by 175 · see citing works
Critical roles of TRAIL in hepatic cell death and hepatic inflammation
Zheng, S. J., Wang, P., Tsabary, G., & Chen, Y. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19255 · Cited by 173 · see citing works
van Nunen, A. B., Hansen, B. E., Suh, D. J., Löhr, H. F., Chemello, L., Fontaine, H., Heathcote, J., Song, B. C., Janssen, H. L. A., de Man, R. A., et al. (2003) · Gut · doi:10.1136/gut.52.3.420 · Cited by 171 · see citing works
The Origin of the Synergistic Effect of Muramyl Dipeptide with Endotoxin and Peptidoglycan
Wolfert, M. A., Murray, T. F., Boons, G., & Moore, J. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204885200 · Cited by 156 · see citing works
Critical roles of TRAIL in hepatic cell death and hepatic inflammation
Zheng, S. J., Wang, P., Tsabary, G., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419255 · Cited by 150 · see citing works
TRAIL Inhibits Tumor Growth but Is Nontoxic to Human Hepatocytes in Chimeric Mice
Hao, C., Song, J. H., Hsi, B., Lewis, J. T., Song, D. K., Petruk, K. C., Tyrrell, D., & Kneteman, N. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2599 · Cited by 147 · see citing works
Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding
Soares‐Weiser, K., Brezis, M., Tur-Kaspa, R., et al. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002907 · Cited by 144 · see citing works
Involvement of TRAIL and its receptors in viral hepatitis
Mundt, B., Kühnel, F., Zender, L., Paul, Y., Tillmann, H. L., Trautwein, C., Manns, M. P., & Kubicka, S. (2002) · The FASEB Journal · doi:10.1096/fj.02-0537fje · Cited by 142 · see citing works
Colonno, R. J., Genovesi, E. V., Medina, I., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/324003 · Cited by 141 · see citing works
Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease
van Heel, D. A. (2005) · Gut · doi:10.1136/gut.2005.065888 · Cited by 131 · see citing works
Long-term survival and cause-specific mortality in patients with cirrhosis of the liver
Sørensen, H. T., Thulstrup, A. M., Mellemkjar, L., et al. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00531-0 · Cited by 129 · see citing works
Obermeier, F., Dunger, N., Strauch, U., Grunwald, N., HERFARTH, H., Schölmerich, J., & Falk, W. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02288.x · Cited by 125 · see citing works
Randomized clinical trials in Hepatology: Predictors of quality
Gluud, L. L., Nikolova, D., & Gluud, C. N. (1999) · Hepatology · doi:10.1002/hep.510300510 · Cited by 115 · see citing works
Self-citationDiehl, A. M. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.012 · Cited by 115 · see citing works
Poynard, T., Naveau, S., Doffoel, M., Boudjema, K., Vanlemmens, C., Mantion, G., Messner, M., Launois, B., Samuel, D., Cherqui, D., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80269-4 · Cited by 110 · see citing works
Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis
Rambaldi, A., & Gluud, C. N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002148.pub2 · Cited by 107 · see citing works
Self-citationData Quality of Administratively Collected Hospital Discharge Data for Liver Cirrhosis Epidemiology
Vestberg, K., Thulstrup, A. M., Sørensen, H. T., Ottesen, P., Sabroe, S., & Vilstrup, H. (1997) · Journal of Medical Systems · doi:10.1023/a:1022835207287 · Cited by 101 · see citing works
Mundt, B., Wirth, T., Zender, L., Waltemathe, M., Trautwein, C., Manns, M. P., Kühnel, F., & Kubicka, S. (2005) · Gut · doi:10.1136/gut.2004.056929 · Cited by 98 · see citing works
Sauer, P., Hansmann, J., Richter, G. M., et al. (2002) · Endoscopy · doi:10.1055/s-2002-33565 · Cited by 97 · see citing works
Defensin-mediated innate immunity in the small intestine
Ouellette, A. J. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2003.10.010 · Cited by 96 · see citing works
Long‐Term Follow‐up of Chronic Hepatitis B Virus Infection in Children of Different Ethnic Origins
Marx, G., Martin, S. R., Chicoine, J.-F., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/341508 · Cited by 93 · see citing works
Tang, B., Kruger, W. D., Chen, G., Shen, F., Lin, W. Y., Mboup, S., London, W. T., & Evans, A. A. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10559 · Cited by 88 · see citing works
Influence of the pharmaceutical industry
Schofield, T. (1983) · BMJ · doi:10.1136/bmj.287.6407.1802-a · Cited by 86 · see citing works
THE VALIDITY OF THE MICHIGAN ALCOHOLISM SCREENING TEST (MAST)
Storgaard, H., Nielsen, S. D., & Gluud, C. N. (1994) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045578 · Cited by 85 · see citing works
Self-citationRoberts, S. E., Goldacre, M. J., & Yeates, D. (2005) · Gut · doi:10.1136/gut.2004.058636 · Cited by 85 · see citing works
Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2
Mori, E., Thomas, M., Motoki, K., Nakazawa, K., Tahara, T., Tomizuka, K., Ishida, I., & Kataoka, S. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401331 · Cited by 84 · see citing works
Janssen, H. L. A., Higuchi, H., Abdulkarim, A., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00265-4 · Cited by 81 · see citing works
Chan, H. L., Tsang, S. W., Hui, Y., Leung, N. W. Y., Chan, F. K. L., & Sung, J. J. �. (2002) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2002.00385.x · Cited by 75 · see citing works
Pawlotsky, J., & McHutchison, J. G. (2004) · Hepatology · doi:10.1002/hep.20065 · Cited by 65 · see citing works
The impact of c-met/scatter factor receptor on dendritic cell migration
Kurz, S. M., Diebold, S. S., Hieronymus, T., Gust, T. C., Bartůněk, P., Sachs, M., Birchmeier, W., & Zenke, M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7 · Cited by 58 · see citing works
Quality assessment of reports on clinical trials in the Journal of Hepatology
Gluud, C. N., & Nikolova, D. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80021-4 · Cited by 58 · see citing works
Self-citationProgress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9
Vollmer, J. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.5.673 · Cited by 56 · see citing works
Anabolic-androgenic steroids for alcoholic liver disease
Rambaldi, A., & Gluud, C. N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003045.pub2 · Cited by 51 · see citing works
Self-citationPrevention of Hepatocellular Carcinoma
Colombo, M., & Donato, M. F. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871195 · Cited by 50 · see citing works
Developments in liver transplantation
Neuberger, J. (2004) · Gut · doi:10.1136/gut.2003.024927 · Cited by 49 · see citing works
Hazardous and harmful drinking: a comparison of the AUDIT and CAGE screening questionnaires
McCusker, M. (2002) · QJM · doi:10.1093/qjmed/95.9.591 · Cited by 47 · see citing works
Propylthiouracil for alcoholic liver disease
Fede, G., Germani, G., Gluud, C. N., Gurusamy, K. S., & Burroughs, A. K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002800.pub3 · Cited by 45 · see citing works
Self-citationToll-like receptor 9–induced type I IFN protects mice from experimental colitis
Katakura, K., Lee, J., Rachmilewitz, D., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522996 · Cited by 44 · see citing works
PREVALENCE OF ALCOHOL PROBLEMS AMONG ADULT SOMATIC IN-PATIENTS OF A COPENHAGEN HOSPITAL
Nielsen, S. D., Storgaard, H., Moesgaard, F., & Gluud, C. N. (1994) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045587 · Cited by 40 · see citing works
Self-citationD’Amico, G., Pagliaro, L., Pietrosi, G., & Tarantino, I. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002233 · Cited by 37 · see citing works
Management of portal hypertension
Samonakis, D. N., Triantos, C. K., Thalheimer, U., et al. (2004) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.020446 · Cited by 36 · see citing works
Modulation of TRAIL Signaling for Cancer Therapy
Fulda, S., & Debatin, K. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)67015-4 · Cited by 34 · see citing works
Validity of randomized clinical trials in gastroenterology from 1964–2000
Gluud, L. L., Frederiksen, S. L., & Gluud, C. N. (2002) · Gastroenterology · doi:10.1053/gast.2002.32390 · Cited by 34 · see citing works
Self-citationAntibiotics for spontaneous bacterial peritonitis in cirrhotics
Soares‐Weiser, K., Brezis, M., & Leibovici, L. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002232 · Cited by 32 · see citing works
Funding, disease area, and internal validity of hepatobiliary randomized clinical trials
Gluud, L. L., & Gluud, C. N. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.07067.x · Cited by 30 · see citing works
Self-citationTrials and errors in clinical research
Gluud, C. N. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90459-2 · Cited by 27 · see citing works
Self-citationInterventions for paracetamol (acetaminophen) overdoses
Brok, J. S., Buckley, N. A., & Gluud, C. N. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003328 · Cited by 27 · see citing works
Self-citationA 20-year prospective study of cirrhosis.
Hislop, W. S. (1981) · BMJ · doi:10.1136/bmj.282.6266.819-b · Cited by 26 · see citing works
Relative Citation Impact of Various Study Designs in the Health Sciences
(2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000173954.21555.b6 · Cited by 26 · see citing works
Fiorucci, G., Vannucchi, S., Chiantore, M. V., et al. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381729 · Cited by 25 · see citing works
Anti-Interleukin-12 Antibody for Active Crohn’s disease
Lebiedz, P., & Kucharzik, T. F. (2005) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2005-858184 · Cited by 25 · see citing works
Kürstein, P., Gluud, L. L., Willemann, M., Olsen, K. R., Kjellberg, J., Søgaard, J., & Gluud, C. N. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.017 · Cited by 23 · see citing works
Self-citationCritical roles of c-Rel in autoimmune inflammation and helper T cell differentiation
Hilliard, B. A., Mason, N. J., Xu, L., Sun, J., Lamhamedi-Cherradi, S.-E., Liou, H., Hunter, C. A., & Chen, Y. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215254 · Cited by 19 · see citing works
Anabolic-androgenic steroids for alcoholic liver disease
Rambaldi, A., Iaquinto, G., & Gluud, C. N. (2003) · doi:10.1002/14651858.cd003045 · Cited by 17 · see citing works
Self-citationCampbell, M. S. (2006) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70454-9 · Cited by 16 · see citing works
Rates of liver cirrhosis rise in England, fall in Europe
Vass, A. (2001) · BMJ · doi:10.1136/bmj.323.7326.1388 · Cited by 12 · see citing works
(2005) · Journal of Hepatology · doi:10.1016/s0168-8278(05)81889-6 · Cited by 10 · see citing works
PHYSICIAN'S INFORMATION ABOUT ALCOHOL PROBLEMS AT HOSPITALISATION OF ALCOHOL MISUSERS
Nielsen, S. D., & Gluud, C. N. (1992) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045317 · Cited by 8 · see citing works
Self-citationFunding, disease area, and internal validity of hepatobiliary randomized clinical trials
Kjaergard, L. L. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05484-9 · Cited by 6 · see citing works
(2005) · Journal of Hepatology · doi:10.1016/s0168-8278(05)81908-7 · Cited by 6 · see citing works
Doctor wins battle against GMC's decision to strike him off
Dyer, C. (2001) · BMJ · doi:10.1136/bmj.323.7326.1388a · Cited by 3 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [32]Gluud C, Als-Nielsen B, D’Amico G, et al. The Cochrane Hepato-Biliary Group. About The Cochrane Collaboration. Collaborative Review Groups (CRGs)) 2005, Issue 2. Oxford: Update Software, 2005, art. No, LIVER.
Cited by
Sorted by citations
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Mokdad, A. A., Lopez, A. D., Shahraz, S., Lozano, R., Mokdad, A. H., Stanaway, J., Murray, C. J., & Naghavi, M. (2014) · BMC Medicine · doi:10.1186/s12916-014-0145-y · Cited by 1,129 · see citing works
- Authors
- Gluud, C.
- Affiliations
- Copenhagen University Hospital (DK)
- Corresponding author
- Gluud, C
- ORCID
- Gluud, C
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2005-10-13
- Volume
- 54
- Issue
- 11
- Pages
- 1523-1526
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC1774736
- OpenAlex
- W1983217976
- Cited by
- 17
- References
- 143
- Citations by year
- 2024: 1 · 2018: 1 · 2017: 1 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 1
- FWCI
- 0.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gut (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver cirrhosis, mortality, liver disease, hamstring injury, return to sport, injury recurrence, strength deficits, platelet-rich plasma, Nordic hamstring exercise, injury prevention
- MeSH terms
- England, Epidemiologic Methods, Humans, Liver Cirrhosis, Mortality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
